Title: Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.
Journal: European journal of medicinal chemistry 20120601
869634-04-8
53968-19-7
71576-05-1
71576-04-0
2173100-96-2
536729-71-2
1105192-73-1 | (6-OXO-3-PYRIDIN-4-YLPYRIDAZIN-1(6(H))-YL)ACETIC ACID | AA01AQ6S | MFCD16652646
1204298-15-6 | 1-(4-FLUOROBENZYL)-6-MERCAPTO-1,5-DIHYDRO-4H-PYRAZOLO[3,4-D]PYRIMIDIN-4-O+ | AA01AQHX | MFCD16631864
211033-59-9 | 3-(2-Hydroxy-ethylamino)-1-phenyl-propan-1-one hydrochloride | AA01AQV7 | MFCD04423352
1105193-50-7 | 5-(1-Naphthyl)isoxazole-3-carboxylic acid | AA01AR1E | MFCD07377191
1040724-73-9 | 3-(1H-INDOL-3-YL)-1H-PYRAZOL-5-AMINE | AA01AR8K | MFCD09743154
1040662-56-3 | 6-CHLORO-N-(4-CHLORO-2-METHYLPHENYL)-1-METHYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN+ | AA01ARI2 | MFCD11518858
1171346-38-5 | 1-(7-amino-1,2,3,4-tetrahydroquinolin-1-yl)-2-methoxyethan-1-one | AA01AROR | MFCD11987119
1448050-07-4 | 4-[(2-Furylmethyl)sulfonyl]piperidine hydrochloride | AA01ARVA | MFCD24842730
1925-54-8 | 1-(BROMOMETHYL)-7,7-DIMETHYLBICYCLO[2.2.1]HEPTAN-2-ONE | AA01AS0N | MFCD00830482
1820665-00-6 | 3-[(4-Chlorophenyl)sulfonyl]azetidine hydrochloride | AA01ASYZ | MFCD26792960
Journal: European journal of medicinal chemistry20120601